Eosinophils: Structure and functions;Le polynucléaire éosinophile: Structure et fonctions

Presse Medicale

Volumn 35, Issue 1 II, 2006, Pages 113-124

  Decot, Véronique ^a   Capron, Monique ^b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; COMPLEMENT RECEPTOR; CYTOKINE; CYTOKINE RECEPTOR; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PEROXIDASE; EOSINOPHIL PROTEIN X; FREE RADICAL; IMMUNOGLOBULIN RECEPTOR; PLATELET DERIVED GROWTH FACTOR; THROMBOCYTE ACTIVATING FACTOR; VASCULOTROPIN; FC RECEPTOR; GROWTH PROMOTOR; IMMUNOLOGIC FACTOR;

CELL ACTIVITY; CELLULAR IMMUNITY; CYTOTOXICITY; EOSINOPHIL; HUMAN; IMMUNOMODULATION; INFECTION; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; LEUKOCYTE STRUCTURE; MEMBRANE MARKER; NEUTROPHIL; PROTEIN EXPRESSION; REVIEW; COMPARATIVE STUDY; DEGRANULATION; IMMUNOLOGY; PHYSIOLOGY; ULTRASTRUCTURE;

CELL DEGRANULATION; EOSINOPHILS; GROWTH SUBSTANCES; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; RECEPTORS, COMPLEMENT; RECEPTORS, CYTOKINE; RECEPTORS, FC; RECEPTORS, IMMUNOLOGIC;

EID: 33644871845     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(06)74534-1     Document Type: Article

References (90)

1. Straumann A, Simon HU. The physiological and pathophysiological roles of eosinophils in the gastrointestinal tract. Allergy. 2004; 59:15-25.
2. Baumhueter S, Dybdal N, Kyle C, Lasky LA. Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin. Blood. 1994; 84: 2554-65.
3. Edwards BS, Curry MS, Tsuji H, Brown D, Larson RS, Sklar LA. Expression of P-selectin at low site density promotes selective attachment of eosinophils over neutrophils. J Immunol. 2000; 165: 404-10.
4. Satoh T, Knowles A, Li MS, Sun L, Tooze JA, Zabucchi G, Spry CJ. Expression of lacto-N-fucopentaose III (CD15)- and sialyl-Lewis X-bearing molecules and their functional properties in eosinophils from patients with the idiopathic hypereosinophilic syndrome. Immunology. 1994; 83: 313-8.
5. Bochner BS, Luscinskas FW, Gimbrone MA Jr, Newman W, Sterbinsky SA, Derse-Anthony CP et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med. 1991; 173: 1553-7.
6. Hartnell A, Moqbel R, Walsh GM, Bradley B. Kay AB. Fc gamma and CD11/CD18 receptor expression on normal density and low density human eosinophils. Immunology. 1990; 69: 264-70.
7. Erle DJ, Briskin MJ, Butcher EC, Garcia-Pardo A. Lazarovits AI, Tidswell M. Expression and function of the MAdCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes. J Immunol. 1994; 153: 17-528.
8. Czech W, Krutmann J, Budnik A, Schopf E, Kapp A. Induction of intercellular adhesion molecule 1 (ICAM-1) expression in normal human eosinophils by inflammatory cytokines. J Invest Dermatol. 1993; 100: 417-23.
9. Morton HC, van Egmond M, van de Winkel JG. Structure and function of human IgA Fc receptors (Fc alpha R). Crit Rev Immunol. 1996; 16: 423-40.
10. van Egmond M, van Vuuren AJ, Morton HC, van Spriel AB, Shen L. Hofhuis F M et al. Human immunoglobulin A receptor (FcalphaRI, CD89) function in transgenic mice requires both FcR gamma chain and CR3 (CD11b/CD18). Blood. 1999; 93: 4387-94.
11. Lamkhioued B, Gounni AS, Gruart V, Pierce A, Capron A, Capron M. Human eosinophils express a receptor for secretory component. Role in secretory IgA-dependent activation. Eur J Immunol. 1995; 25: 117-25.
12. Motegi Y, Kita H. Interaction with secretory component stimulates effector functions of human eosinophils but not of neutrophils. J Immunol. 1998; 161: 4340-6.
13. Decot V, Woerly G, Loyens M, Loiseau S, Quatannens B, Capron M et al. Heterogeneity of IgA receptors expression on human, mouse and rat eosinophils. J Immunol. 2005; 174: 628-35.
14. Tomassini M, Tsicopoulos A, Tai PC, Gruart V, Tonnel AB, Prin L et al. Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation. J Allergy Clin Immunol. 1991; 88: 365-75.
15. Dombrowicz D, Woerly G, Capron M. IgE receptors on human eosinophils. In Human eosinophils: biological and clinical aspects. Chemical Immunol. 2000; M. G., ed. (Karger): 63-76.
16. Seminario MC, Saini SS, MacGlashan DW Jr, Bochner BS. Intracellular expression and release of Fc epsilon RI alpha by human eosinophils. J Immunol. 1999; 162: 6893-900.
17. Kayaba H, Dombrowicz D, Woerly G, Papin JP, Loiseau S, Capron M. Human eosinophils and human high affinity IgE receptor transgenic mouse eosinophils express low levels of high affinity IgE receptor, but release IL-10 upon receptor activation. J Immunol. 2001; 167: 995-1003.
18. Capron M, Capron A. Immunoglobulin E and effector cells in schistosomiasis. Science. 1994; 264: 1876-7.
19. Daëron M. Fc receptor biology. Annual Review in Immunology. 1997; 203-34.
20. Elsner J, Oppermann M, Kapp A. Detection of C5a receptors on human eosinophils and inhibition of eosinophil effector functions by anti-C5a receptor (CD88) antibodies. Eur J Immunol. 1996; 26: 1560-4.
21. Sun Q, Jones K, McClure B, Cambareri B, Zacharakis B, Iversen PO. et al. Simultaneous antagonism of interleukin-5, granulocyte-macrophage colony-stimulating factor, and interleulkin-3 stimulation of human eosinophils by targetting the common cytokine binding site of their receptors. Blood. 1999; 94: 1943-51.
22. Plumas J, Gruart V, Capron M, Capron A, Prin L. The interleukin 2 receptor in the hypereosinophilic syndrome. Leuk Lymphoma. 1992; 8: 449-57.
23. Hoontrakoon R, Chu HW, Gardai SJ, Wenzel SE, McDonald P, Fadok VA et al. Interleukin-15 inhibits spontaneous apoptosis in human eosinophils via autocrine production of granulocyte macrophage-colony stimulating factor and nuclear factor-kappaB activation. Am J Respir Cell Mol Biol. 2002; 26: 404-12.
24. Gounni AS, Nutku E, Koussih L, Aris F, Louahed J, Levitt RC et al. IL-9 expression by human eosinophils: regulation by IL-1beta and TNF-alpha. J Allergy Clin Immunol. 2000; 106: 460-6.
25. Luttmann W, Franz P, Schmidt S, Barth J, Matthys, H, Virchow JC Jr. Inhibition of HLA-DR expression on activated human blood eosinophils by transforming growth factor-beta1. Scand J Immunol. 1998; 48: 667-71.
26. Dubois GR, Schweizer RC, Versluis C, Bruijnzeel-Koomen CA, Bruijnzeel PL. Human eosinophils constitutively express a functional interleukin-4 receptor: interleukin-4 -induced priming of chemotactic responses and induction of PI-3 kinase activity. Am J Respir Cell Mol Biol. 1998; 19: 691-9.
27. Nutku E, Zhuang Q, Soussi-Gounni A, Aris F, Mazer BD, Hamid Q. Functional expression of IL-12 receptor by human eosinophils: IL-12 promotes eosinophil apoptosis. J Immunol. 2001; 167: 1039-46.
28. Wang W, Tanaka T, Okamura H, Sugita M, Higa S, Kishimoto T et al. Interleukin-18 enhances the production of interleukin-8 by eosinophils. Eur J Immunol 2001; 31: 1010-6.
29. Hartnell A, Kay AB, Wardlaw AJ. IFN-gamma induces expression of Fc gamma RIII (CD16) on human eosinophils. J Immunol. 1992; 148: 1471-8.
30. Ishiharu C, Ochiai K, Kagami M, Matsuyama G, Koya N, Tomioka H. Interferon-gamma receptor beta-chain expression and formation of alpha- and beta-chain complexes after receptor conjugation on human peripheral eosinophils. Int Arch Allergy Immunol. 1998; 117 Suppl 1: 72-6.
31. Aldebert D, Lamkhioued B, Desaint C, Gounni AS, Goldman M, Capron A et al. Eosinophils express a functional receptor for interferon alpha: inhibitory role of interferon alpha on the release of mediators. Blood. 1996; 87: 2354-60.
32. Mallett S, Barclay AN. A new superfamily of cell surface proteins related to the nerve growth factor receptor. Immunol Today. 1991; 12: 220-3.
33. Eisma R J, Allen JS, Lafreniere D, Leonard G, Kreutzer DL. Eosinophil expression of transforming growth factor-beta and its receptors in nasal polyposis: role of the cytokines in this disease process. Am J Otolaryngol. 1997; 18: 405-11.
34. Velazguez JR, Lacy P, Mahmudi-Azer S, Moqbel R. Effects of interferon-gamma on mobilization and release of eosinophil- derived RANTES. Int Arch Allergy Immunol. 1999; 118: 447-9.
35. Jinguan T, Jing C, Jacobi HH, Reimert CM, Millner A, Quan S et al. CXCR3 expression and activation of eosinophils: role of IFN-gamma- inducible protein-10 and monokine induced by IFN-gamma. J Immunol. 2000; 165: 1548-56.
36. Daugherty BL, Siciliano SJ, DeMartino JA, Malkowitz L, Sirotina A, Springer MS. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med. 1996; 183: 2349-54.
37. Dunzendorfer S, Kaneider NC, Kaser A, Woell E, Frade JM, Mellado M et al. Functional expression of chemokine receptor 2 by normal human eosinophils. J Allergy Clin Immunol. 2001; 108: 581-7.
38. Nagase H, Miyamasu M, Yamaguchi, M, Fujisawa T, Ohta K, Yamamoto K et al. Expression of CXCR4 in eosinophils: functional analyses and cytokine-mediated regulation. J Immunol. 2000; 164: 5935-43.
39. Shi HZ. Eosinophils function as antigen-presenting cells. J Leukoc Biol. 2004; 76: 520-7.
40. Ohkawara Y, Lim KG, Xing Z, Glibetic M, Nakano K, Dolovich J et al. CD40 expression by human peripheral blood eosinophils. J Clin Invest. 1996; 97: 1761-6.
41. Pinto A, Aldinucci D, Gloghini A, Zagonel V, Degan M, Perin V et al. The role of eosinophils in the pathobiology of Hodgkin's disease. Ann Oncol. 1997; 8: 89-96.
42. Ferland C, Flamand N, Davoine F, Chakir J, Laviolette M. IL-16 activates plasminogen-plasmin system and promotes human eosinophil migration into extracellular matrix via CCR3-chemokine-mediated signaling and by modulating CD4 eosinophil expression. J Immunol. 2004; 173: 4417-24.
43. Woerly G, Roger N, Loiseau S, Dombrowicz D, Capron A, Capron M. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin A complexes. J Exp Med. 1999; 190: 487-95.
44. Yokomizo T, Izumi T, Chang K. Takuwa Y, Shimizu TA G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature. 1997; 387: 620-4.
45. Gervais FG, Cruz RP, Chateauneuf A, Gale S, Sawyer N, Nantel F et al. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J Allergy Clin Immunol. 2001; 108: 982-8.
46. Monneret G, Gravel S, Diamond M, Rokach J, Powell WS. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood. 2001; 98: 1942-8.
47. Urasaki T, Takasaki J, Nagasawa T, Ninomiya H. Pivotal role of 5-lipoxygenase in the activation of human eosinophils: platelet-activating factor and interleukin-5 induce CD69 on eosinophils through the 5-lipoxygenase pathway. J Leukoc Biol. 2001; 69: 105-12.
48. Hansel TT, De Vries IJ, Carballido JM, Braun RK, Carballido-Perrig N, Rihs S et al. Induction and function of eosinophil intercellular adhesion molecule-1 and HLA-DR. J Immunol. 1992; 149: 2130-6.
49. Hossain M, Okubo Y, Horie S, Sekiguchi M. Analysis of recombinant human tumour necrosis factor-alpha-induced CD4 expression on human eosinophils. Immunology. 1996; 88: 301-7.
50. Thomas EL, Bozeman PM, Jefferson MM, King CC. Oxidation of bromide by the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase. Formation of bromamines. J Biol Chem. 1995; 270: 2906-13.
51. Kita H, Ohnishi T, Okubo Y, Weiler D, Abrams JS, Gleich GJ. Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med. 1991; 174: 745-8.
52. Cortegano I, del Pozo V, Cardaba B, de Andres B, Gallardo S, del Amo A et al. Galectin-3 down-regulates IL-5 gene expression on different cell types. J Immunol. 1998; 161: 385-9.
53. Bandeira-Melo C, Sugiyama K, Woods LJ, Weller PF. Cutting edge: eotaxin elicits rapid vesicular transport-mediated release of preformed IL-4 from human eosinophils. J Immunol. 2001; 166: 4813-7.
54. Melani C, Mattia GF, Silvani A, Care A, Rivoltini L, Parmiani G, Colombo M P. Interleukin-6 expression in human neutrophil and eosinophil peripheral blood granulocytes. Blood. 1993; 81: 2744-9.
55. Rossi AG, Haslett C, Hirani N, Greening AP, Rahman I, Metz CN et al. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J Clin Invest. 1998; 101: 2869-74.
56. Nakajima H, Gleich GJ, Kita H. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J Immunol. 1996; 156: 4859-66.
57. Capron M, Dombrowicz D. Eosinophiles, parasites et allergie: de la biologie à la clinigue. Journal de la Société de Biologie. 2002; 196: 23.
58. Gounni AS, Gregory B, Nutku E, Aris F, Latifa K, Minshall E et al. Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils. Blood. 2000; 96: 2163-71.
59. Crepaldi L, Gasperini S, Lapinet J A, Calzetti F, Pinardi C, Liu Y et al. Up-regulation of IL-10R1 expression is reguired to render human neutrophils fully responsive to IL-10. J Immunol. 2001; 167: 2312.
60. Woerly G, Lacy P, Younes A B, Roger N, Loiseau S, Moqbel R et al. Human eosinophils express and release IL-13 following CD28-dependent activation. J Leukoc Biol. 2002; 72: 769-79.
61. Lim KG, Wan HC, Bozza PT, Resnick MB, Wong DT, Cruikshank WW et al. Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES. J Immunol. 1996; 156: 2566-70.
62. Grewe M, Czech W, Morita A, Werfel T, Klammer M, Kapp A et al. Human eosinophils produce biologically active IL-12: implications for control of T cell responses. J Immunol. 1998; 161: 415-20.
63. Fujisawa T, Kato Y, Nagase H, Atsuta J, Terada A, Iguchi K et al. Chemokines induce eosinophil degranulation through CCR-3. J Allergy Clin Immunol. 2000; 106: 507-13.
64. Nakajima T, Yamada H, Iikura M, Miyamasu M, Izumi S, Shida H et al. Intracellular localization and release of eotaxin from normal eosinophils. FEBS Lett. 1998; 434: 226-30.
65. Yousefi S, Hemmann S, Weber M, Holzer C, Hartung K, Blaser K, Simon H U. IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. J Immunol. 1995; 154: 5481-90.
66. Izumi S, Hirai K, Miyamasu M, Takahashi Y, Misaki Y, Takaishi T et al. Expression and regulation of monocyte chemoattractant protein-1 by human eosinophils. Eur J Immunol. 1997; 27: 816-24.
67. Costa J J, Matossian K, Resnick MB, Beil WJ, Wong DT, Gordon J R et al. Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha. J Clin Invest. 1993; 91: 2673-84.
68. Elovic AE, Ohyama H, Sauty A, McBride J, Tsuji T, Nagai M et al. IL-4-dependent regulation of TGF-alpha and TGF-beta1 expression in human eosinophils. J Immunol. 1998; 160: 6121-7.
69. Hartman M, Piliponsky AM, Temkin V, Levi-Schaffer F. Human peripheral blood eosinophils express stem cell factor. Blood. 2001; 97: 1086-91.
70. Kobayashi H, Gleich, GJ, Butterfield JH, Kita H. Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood. 2002; 99: 2214-20.
71. Ohno I, Nitta Y, Yamauchi K, Hoshi H, Honma M, Woolley K et al. Eosinophils as a potential source of platelet-derived growth factor B- chain (PDGF-B) in nasal polyposis and bronchial asthma. Am J Respir Cell Mol Biol. 1995; 13: 639-47.
72. Powell PP, Klagsbrun M, Abraham JA, Jones RC. Eosinophils expressing heparin-binding EGF-like growth factor mRNA localize around lung microvessels in pulmonary hypertension. Am J Pathol. 1993; 143: 78493.
73. Horiuchi T, Weller PF. Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol. 1997; 17: 70-7.
74. Bandeira-Melo C, Bozza PT, Weller PF. The cellular biology of eosinophil eicosanoid formation and function. J Allergy Clin Immunol. 2002; 109: 393-400.
75. Cromwell O, Wardlaw AJ, Champion A, Moqbel R, Osei D, Kay AB. IgG-dependent generation of platelet-activating factor by normal and low density human eosinophils. J Immunol. 1990; 145: 3862-8.
76. Bartemes KR, McKinney S, Gleich GJ, Kita H. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG. J Immunol. 1999; 162: 2982-9.
77. Desreumaux P, Capron M. Eosinophils in allergic reactions. Curr Opin Immunol. 1996; 8: 790-5.
78. Kita H, Adolphson C, Gleich GJ. Biology of eosinophils. In: Middleton E, Ellis E, Yunginger J, Reed C, Adkinson F, Busse BW, eds. Allergy. St Louis: Mosby; 1998. p. 242-60.
79. Rosenberg HF, Domachowske JB. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol. 2001; 70: 691-8.
80. Munitz A, Levi-Schaffer F. Eosinophils: "new" roles for "old" cells. Allergy. 2004; 59: 268-75.
81. Gomolin HI, Yamaguchi Y, Paulpillai AV, Dvorak LA, Ackerman SJ, Tenen DG. Human eosinophil Charcot-Leyden crystal protein: cloning and characterization of a lysophospholipase gene promoter. Blood. 1993; 82: 1868-74.
82. Dubucquoi S, Capron M. L'éosinophile: une cellule à deux visages dans la réponse inflammatoire. In: Russo-Marie F, Peltier A, Polla B, eds. L'inflammation. John Libbey Eurotext; 1998: 55-68.
83. Capron M, Capron A, Dombrowicz D. L'éosinophile, une cellule aux multiples facettes. Rev Fr Allergol Immunol Clin. 2002: 213-8.
84. Dunne DW, Richardson BA, Jones FM, Clark M, Thorne KJ, Butterworth AE. The use of mouse/human chimaeric antibodies to investigate the roles of different antibody isotypes, including IgA2, in the killing of Schistosoma mansoni schistosomula by eosinophils. Parasite Immunol. 1993; 15: 181-5.
85. Gounni AS, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, Capron A et al. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature. 1994; 367: 183-6.
86. Rothenberg ME. Eosinophilia. N Engl J Med. 1998; 338: 1592-600.
87. Persson T, Andersson P, Bodelsson M, Laurell M, Malm J, Egesten A. Bactericidal activity of human eosinophilic granulocytes against Escherichia coli. Infect Immun. 2001; 69: 3591-6.
88. Dombrowicz D, Capron M. Eosinophils, allergy and parasites. Curr Opin Immunol. 2001; 13: 716-20.
89. Lacy P, Moqbel R. Immune effector functions of eosinophils in allergic airway inflammation. Curr Opin Allergy Clin Immunol. 2001; 1: 79-84.
90. Lucey DR, Dorsky DI, Nicholson-Weller A, Weller PF. Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120. J Exp Med. 1989; 169: 327-32.